Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Motilal Oswal S&P BSE Healthcare ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.11 |
Equity |
99.89 |
|
|
Concentration Analysis |
Top 5 Holdings |
40.21% |
Top 10 Holdings |
57.76% |
Top 25 Holdings |
79.13% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
75.66 |
Healthcare |
24.23 |
Cash |
0.11 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.52 |
PE Ratio |
36.47 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
15.31 |
Cipla Limited |
6.71 |
Max Healthcare Institute Limited |
6.38 |
Dr Reddys Laboratories Limited |
6.03 |
DIVI LABORATORIES LTD |
5.78 |
Apollo Hospitals Enterprise Limited |
5.58 |
Lupin Limited |
4.09 |
Fortis Health Care Ltd |
2.71 |
Aurobindo Pharma Limited |
2.66 |
Torrent Pharmaceuticals Limited |
2.51 |
Alkem Laboratories Limited |
2.17 |
Zydus Lifesciences Limited |
1.99 |
MANKIND PHARMA LIMITED |
1.99 |
Laurus Labs Limited |
1.87 |
Glenmark Pharmaceuticals Limited |
1.77 |
IPCA Laboratories Limited |
1.58 |
Biocon Limited |
1.31 |
Krishna Inst of Medical Sciences Ltd. |
1.21 |
Piramal Pharma Limited |
1.16 |
Syngene International Limited |
1.10 |
Suven Pharmaceuticals Limited |
1.09 |
Abbott India Limited |
1.08 |
Concord Biotech Limited |
1.04 |
J B Chemicals and Pharma Ltd |
1.02 |
Neuland Laboratories Limited |
0.99 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|